BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24174293)

  • 1. High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potential.
    Uranbileg B; Enooku K; Soroida Y; Ohkawa R; Kudo Y; Nakagawa H; Tateishi R; Yoshida H; Shinzawa S; Moriya K; Ohtomo N; Nishikawa T; Inoue Y; Tomiya T; Kojima S; Matsuura T; Koike K; Yatomi Y; Ikeda H
    Int J Cancer; 2014 May; 134(9):2189-98. PubMed ID: 24174293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased activity of serum mitochondrial isoenzyme of creatine kinase in hepatocellular carcinoma patients predominantly with recurrence.
    Soroida Y; Ohkawa R; Nakagawa H; Satoh Y; Yoshida H; Kinoshita H; Tateishi R; Masuzaki R; Enooku K; Shiina S; Sato T; Obi S; Hoshino T; Nagatomo R; Okubo S; Yokota H; Koike K; Yatomi Y; Ikeda H
    J Hepatol; 2012 Aug; 57(2):330-6. PubMed ID: 22521349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum mitochondrial creatine kinase activity as a risk for hepatocarcinogenesis in chronic hepatitis C patients.
    Enooku K; Nakagawa H; Soroida Y; Ohkawa R; Kageyama Y; Uranbileg B; Watanabe N; Tateishi R; Yoshida H; Koike K; Yatomi Y; Ikeda H
    Int J Cancer; 2014 Aug; 135(4):871-9. PubMed ID: 24420733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASB9 interacts with ubiquitous mitochondrial creatine kinase and inhibits mitochondrial function.
    Kwon S; Kim D; Rhee JW; Park JA; Kim DW; Kim DS; Lee Y; Kwon HJ
    BMC Biol; 2010 Mar; 8():23. PubMed ID: 20302626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of ubiquitous mitochondrial creatine kinase (uMtCK) accelerates tumor growth by inhibiting apoptosis of breast cancer cells and is associated with a poor prognosis in breast cancer patients.
    Qian XL; Li YQ; Gu F; Liu FF; Li WD; Zhang XM; Fu L
    Biochem Biophys Res Commun; 2012 Oct; 427(1):60-6. PubMed ID: 22982673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients.
    Wang RY; Chen L; Chen HY; Hu L; Li L; Sun HY; Jiang F; Zhao J; Liu GM; Tang J; Chen CY; Yang YC; Chang YX; Liu H; Zhang J; Yang Y; Huang G; Shen F; Wu MC; Zhou WP; Wang HY
    Gastroenterology; 2013 Dec; 145(6):1436-48.e1-12. PubMed ID: 23933603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis.
    Mi Y; Li Q; Liu B; Wang D; Liu Z; Wang T; Wang Y; Zang Y; Zhou Y; Wen Y; Ding Y
    Gastric Cancer; 2023 Jan; 26(1):69-81. PubMed ID: 36114400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-suppressive role of HACE1 in hepatocellular carcinoma and its clinical significance.
    Gao ZF; Wu YN; Bai ZT; Zhang L; Zhou Q; Li X
    Oncol Rep; 2016 Dec; 36(6):3427-3435. PubMed ID: 27805249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway.
    Cao J; Chen Y; Fu J; Qian YW; Ren YB; Su B; Luo T; Dai RY; Huang L; Yan JJ; Wu MC; Yan YQ; Wang HY
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S312-23. PubMed ID: 22618716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy.
    Shimizu D; Kanda M; Sugimoto H; Shibata M; Tanaka H; Takami H; Iwata N; Hayashi M; Tanaka C; Kobayashi D; Yamada S; Nakayama G; Koike M; Fujiwara M; Fujii T; Kodera Y
    Int J Oncol; 2017 Feb; 50(2):381-386. PubMed ID: 28101581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
    Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
    Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma.
    Wu X; Chen H; Gao Q; Bai J; Wang X; Zhou J; Qiu S; Xu Y; Shi Y; Wang X; Zhou J; Fan J
    Mol Carcinog; 2014 Apr; 53(4):325-36. PubMed ID: 23169062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma.
    Ng KT; Qi X; Kong KL; Cheung BY; Lo CM; Poon RT; Fan ST; Man K
    Eur J Cancer; 2011 Oct; 47(15):2299-305. PubMed ID: 21683576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.
    Wang H; Li W; Jin X; Cui S; Zhao L
    Eur J Cancer; 2013 Mar; 49(4):974-83. PubMed ID: 23084841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
    Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
    World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma.
    Zhang HX; Jiang SS; Zhang XF; Zhou ZQ; Pan QZ; Chen CL; Zhao JJ; Tang Y; Xia JC; Weng DS
    Oncotarget; 2015 Oct; 6(33):34800-17. PubMed ID: 26430962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling.
    Xie B; Zen Q; Wang X; He X; Xie Y; Zhang Z; Li H
    Int J Oncol; 2015 May; 46(5):2057-66. PubMed ID: 25738261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection.
    Zhao YM; Zhou JM; Wang LR; He HW; Wang XL; Tao ZH; Sun HC; Wu WZ; Fan J; Tang ZY; Wang L
    Cancer; 2012 May; 118(10):2708-17. PubMed ID: 21989785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.